← Pediatrix Medical Group, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $3.2b |
$3.5b
+8.64%
|
$3.6b
+5.46%
|
$3.5b
-3.66%
|
$1.7b
-50.65%
|
$1.9b
+10.22%
|
$2.0b
+3.18%
|
$2.0b
+1.15%
|
$2.0b
+0.92%
|
$1.9b
-4.92%
|
$2.0b
+1.92%
|
|
| General and Administrative Expense | $372.6m | $417.1m | $432.4m | $404.6m | $248.9m | $263.4m | $231.4m | $227.5m | $238.4m | $240.8m | $248.0m | |
| Amortization of Intangible Assets | $60.3m | $68.9m | $72.8m | $48.9m | $7.6m | $8.0m | $6.4m | $5.6m | $7.1m | $5.7m | — | |
| Transformational and restructuring related expenses | — | $0 | $0 | $95.3m | $73.8m | $22.1m | $27.3m | $2.2m | $64.3m | $22.3m | — | |
| Practice supplies and other operating expenses | $118.4m | $120.5m | $122.0m | $112.8m | $90.7m | $100.5m | $121.7m | $124.8m | $117.7m | $79.3m | — | |
| Operating Expenses | $2.6b | $3.0b | $3.2b | $4.6b | $1.6b | $1.7b | $1.8b | $2.0b | $2.1b | $1.7b | $1.7b | |
| Operating Income (Loss) | $571.7m |
$480.1m
-16.02%
|
$445.8m
-7.13%
|
($1.1b)
-354.81%
|
$98.1m
+108.64%
|
$202.9m
+106.78%
|
$172.7m
-14.90%
|
$7.3m
-95.76%
|
($68.7m)
-1038.57%
|
$208.8m
+403.89%
|
$240.7m
+15.25%
|
|
| Investment Income, Net | $2.0m | $4.0m | $4.9m | $5.7m | $17.9m | $13.7m | $3.7m | $4.3m | $5.8m | $19.0m | — | |
| Gain (Loss) on Investments | — | — | — | — | — | — | — | — | — | $20.9m | — | |
| Income (Loss) from Equity Method Investments | $3.2m | $952k | $6.8m | $7.8m | $1.6m | $1.9m | $1.7m | $2.1m | $2.3m | $3.6m | — | |
| Investment and other income | $2.0m | $4.0m | $4.9m | $5.7m | $17.9m | $13.7m | $3.7m | $4.3m | $5.8m | $19.0m | — | |
| Interest Expense (non-operating) | $63.1m | $74.6m | $88.8m | $119.4m | $110.5m | $68.7m | $39.7m | $42.1m | $40.7m | $36.0m | $34.1m | |
| Total non-operating income (expenses) | ($57.9m) | ($69.7m) | ($77.0m) | ($105.9m) | ($91.0m) | ($67.7m) | ($91.3m) | ($55.7m) | ($32.6m) | $7.6m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $513.8m | $410.4m | $368.8m | ($1.2b) | $7.1m | $135.2m | $81.4m | ($48.4m) | ($101.3m) | $216.4m | $226.2m | |
| Income tax (provision) benefit | $189.2m | ($90.0m) | ($100.2m) | $91.9m | ($16.7m) | ($27.2m) | ($18.8m) | ($12.0m) | $2.3m | ($51.0m) | — | |
| Net Income (Loss) Attributable to Parent | $324.9m |
$320.4m
-1.40%
|
$268.6m
-16.15%
|
($1.5b)
-657.54%
|
($796.5m)
+46.82%
|
$131.0m
+116.44%
|
$66.3m
-49.35%
|
($60.4m)
-191.07%
|
($99.1m)
-64.00%
|
$165.4m
+266.94%
|
$174.8m
+5.69%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | ($318k) | — | — | — | — | $27k | ($4k) | $0 | $0 | — | $174.8m | |
| Income (Loss) from Continuing Operations, Per Basic Share | — | — | — | ($14) | ($0) | $1 | $1 | $1 | ($1) | — | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | — | — | ($14) | ($0) | $1 | $1 | $1 | ($1) | — | — | |
| Earnings Per Share, Basic | $3.52 | $3.47 | $2.95 | ($17.94) | ($9.55) | $1.54 | $0.79 | $0.73 | ($1.19) | $1.97 | $2.13 | |
| Earnings Per Share, Diluted | $3.49 | $3.45 | $2.93 | ($17.94) | ($9.55) | $1.53 | $0.79 | $0.73 | ($1.19) | $1.94 | $2.09 | |
| Weighted Average Number of Shares Outstanding, Basic | 92.4m | 92.4m | 91.1m | 83.5m | 83.4m | 84.8m | 83.5m | 82.2m | 83.3m | 84.1m | 81.7m | |
| Weighted Average Number of Shares Outstanding, Diluted | 93.1m | 93.0m | 91.6m | 83.5m | 83.4m | 85.8m | 84.1m | 82.2m | 83.3m | 85.3m | 83.5m | |
| Additional Financial Items | ||||||||||||
| Goodwill, Impairment Loss | — | — | — | $1.4b | — | — | — | $148.3m | $150.6m | — | ($3.6m) | |
| Practice salaries and benefits | $2.0b | $2.3b | $2.5b | $2.5b | $1.2b | $1.3b | $1.4b | $1.4b | $1.4b | $1.3b | — | |
| Depreciation and amortization | $89.3m | $102.9m | $111.3m | $78.9m | $28.4m | $32.1m | $35.6m | $36.2m | $32.2m | $21.8m | $23.1m | |
| Goodwill impairment | — | $0 | $0 | $1.4b | — | $0 | $0 | $148.3m | $150.6m | — | ($3.6m) | |
| Long-lived asset impairments | — | — | — | — | — | — | $0 | $0 | $27.8m | — | — | |
| Loss on disposal of businesses | — | — | — | — | — | — | $0 | $0 | $9.7m | $0 | — | |
| Income (loss) from operations | $571.7m |
$480.1m
-16.02%
|
$445.8m
-7.13%
|
($1.1b)
-354.81%
|
$98.1m
+108.64%
|
$202.9m
+106.78%
|
$172.7m
-14.90%
|
$7.3m
-95.76%
|
($68.7m)
-1038.57%
|
$208.8m
+403.89%
|
$240.7m
+15.25%
|
|
| Net gain on investments in divested businesses | — | — | — | — | — | — | — | $0 | $0 | $20.9m | — | |
| Impairment of strategic investment | — | — | — | — | — | $0 | $0 | ($20.0m) | $0 | — | — | |
| Equity in earnings of unconsolidated affiliate | $3.2m | $952k | $6.8m | $7.8m | $1.6m | $1.9m | $1.7m | $2.1m | $2.3m | $3.6m | — | |
| Unrealized holding gain on investments, net of tax of $526, $374 and $527 | — | — | — | — | $3.5m | ($2.2m) | ($5.1m) | $1.5m | $1.1m | $1.7m | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | ($1.2b) | ($9.6m) | $108.0m | $62.6m | ($60.4m) | ($99.1m) | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | ($347.6m) | ($786.9m) | $22.9m | $3.8m | $0 | $0 | — | — | |
| Total comprehensive income (loss) | — | — | — | — | ($793.0m) | $128.8m | $61.3m | ($58.9m) | ($97.9m) | $167.1m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.